Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EnteroMedics Inc    ETRM

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
More Financials
Company
EnteroMedics, Inc. is a clinical development stage medical device company that engages in the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.Its proprietary neuroblocking technology is designed to... 
More about the company
Latest news on ENTEROMEDICS INC
02/21 ENTEROMEDICS INC. (NASDAQ : ETRM) Files An 8-K Other Events
02/21 ENTEROMEDICS INC : Other Events, Financial Statements and Exhibits (form 8-K)
02/15 ENTEROMEDICS INC. (NASDAQ : ETRM) Files An 8-K Departure of Directors or Certain..
02/15 ENTEROMEDICS INC : Change in Directors or Principal Officers, Financial Statemen..
02/09 ENTEROMEDICS : ETRM) Jumps on Data Publication
02/09 ENTEROMEDICS : Announces Publication of Three-Year Data from vBloc Diabetic Pati..
01/31 ENTEROMEDICS INC : Other Events (form 8-K)
01/25 ENTEROMEDICS INC. (NASDAQ : ETRM) Files An 8-K Other Events
01/24 ENTEROMEDICS INC : Other Events, Financial Statements and Exhibits (form 8-K)
01/23 ENTEROMEDICS : ETRM) Hikes After Climbing Friday
More news
Sector news : Advanced Medical Equipment & Technology - NEC
02/09 Infineon, Cree warn U.S. might block Wolfspeed deal
02/02 EU probes online sales in electronics, video games, hotels
01/31DJTHERMO FISHER SCIENTIFIC : Earnings, Sales Rise
01/31DJDANAHER : Revenue, Profit Rise
01/30DJEUROPEAN MORNING BRIEFING : Corporate Events
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
2016 Medtech Approvals Of The Strange Kind
2015 EnteroMedics Will Do 1 For 15 Reverse Split - This Is Not A Good Way To Start..
2015 ENTEROMEDICS TO REVERSE SPLIT SHARES : 15
2015 EnteroMedics' (ETRM) CEO Dan Gladney on Q3 2015 Results - Earnings Call Trans..
2015 EnteroMedics - Investors Need To Have Realistic Expectations
Advertisement
Chart ENTEROMEDICS INC
Duration : Period :
EnteroMedics Inc Technical Analysis Chart | ETRM | US29365M2089 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus BUY
Number of Analysts 1
Average target price 140 $
Spread / Average Target 2 199%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Dan W. Gladney Chairman, President & Chief Executive Officer
Peter M. Delange Senior VP-Operations & Business Development
Scott P. Youngstrom Chief Financial & Compliance Officer, Secretary
Carl Samuel Goldfischer Independent Class I Director
Nicholas L. Teti Independent Class III Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ENTEROMEDICS INC53.73%21
THERMO FISHER SCIENTIF..11.99%62 702
DANAHER CORPORATION8.94%58 885
BOSTON SCIENTIFIC CORP..16.32%33 334
INTUITIVE SURGICAL, IN..15.95%28 522
PHILIPS-3.22%27 544
More Results